Bioresorbables Plus Access & Closure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Current Status of Trial Outcomes for the Absorb Stent

How does Absorb compare to everolimus-eluting metallic stents?

By Salvatore Cassese, MD, PhD

Understanding the Technical Aspects of Bioresorbable Stent Implantation

The new Absorb polymer-based scaffold requires optimal implantation technique for best results.

By Ashok Seth, FRCP, FACC, FSCAI, FESC, FCSI, DSc, DLitt; Vijay Kumar, MD, DNB; and Babu Ezhumalai, MD, DM, FNB, FISE

How Will New Bioresorbable Polymer Drug-Eluting Stents Impact DAPT Duration?

Current bioresorbable polymer, everolimus-eluting stent technology appears well suited for abbreviated-duration dual-antiplatelet therapy.

By Ian J. Sarembock, MBChB, MD, FACC, and Dean J. Kereiakes, MD, FACC

Next-Generation Fully Bioresorbable Polymer Stents

A summary of technology undergoing testing and a look at what is on the horizon.

By Rémi Kouz, MD, CM, MSc; and Jean-François Tanguay, MD, FACC, FAHA, FESC

Definitions of Bioresorbable Technologies

Improvements in Femoral Access and Closure for TAVR

A focus on early recognition and prompt percutaneous endovascular management of failure of femoral artery percutaneous preclosure.

By Nelson L. Bernardo, MD, and Augusto D. Pichard, MD

Transradial Catheterization: Hemostasis, Patency, and Same-Day Discharge

Transradial catheterization can lead to safer, less costly, and more satisfactory coronary angiography and interventions.

By Chad M. Dugas, MD, and Jeffrey M. Schussler, MD, FACC, FSCAI

Radial PCI

The advantages and limitations of 4- to 5-F guide catheters.

By Tejas Patel, MD, DM, FACC, FSCAI, FESC, and Samir B. Pancholy, MD, FACP, FACC, FSCAI

TAVR Study Chart

Data summaries for TAVR platforms available or being studied in the United States.

Aligning Provider Compensation to Create Value

Tips for optimizing compensation in the new value-based environment.

By Suzette Jaskie, and Joel Sauer

Innovations

An Interview With Ralph G. Brindis, MD

Dr. Brindis discusses updated guidelines for DAPT, accreditation, the development of a national medical device postmarket surveillance system, and more.